• Home
  • FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy.

FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy.

Author List
Menon S, Gracilla D, Breese MR, Lin YP, Dela Cruz F, Feinberg T, de Stanchina E, Galic AF, Allegakoen H, Perati S, Wen N, Heslin A, Horlbeck MA, Weissman J, Sweet-Cordero EA, Bivona TG, Tulpule A
Publication
bioRxiv : the preprint server for biology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/396766240
Publication Year
2025
PubMed ID
37205599
Publication Title
Menon S, Gracilla D, Breese MR, Lin YP, Dela Cruz F, Feinberg T, de Stanchina E, Galic AF, Allegakoen H, Perati S, Wen N, Heslin A, Horlbeck MA, Weissman J, Sweet-Cordero EA, Bivona TG, Tulpule A. FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. bioRxiv. 2025 May 07.
Publication Medline TA
bioRxiv
Date
2025-05-07